Logo-apb

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by
Adv Pharm Bull. 2024;14(1): 67-85. doi: 10.34172/apb.2024.018
PMID: 38585458        PMCID: PMC10997930

Review Article

Transdermal Drug Delivery Systems: A Focused Review of the Physical Methods of Permeation Enhancement

Rifath Sheikh Vaseem 1 ORCID, Alison D’cruz 1, Srishti Shetty 1, Hafsa - 1, Aditya Vardhan 1, Shreya Shenoy R 1, Shirleen Miriam Marques 1, Lalit Kumar 1,2 * ORCID, Ruchi Verma 3

Cited by CrossRef: 0

1- Upadhyay A, Tripathi S, Malviya A, Kohli K, Mishra S. Transdermal Therapeutics for Psoriasis Management Using Minimally Invasive Approaches. J Pharm Innov. 2025;20(6) [Crossref]
2- Elnaggar M, Mekkawy A, Taha A, Abdel-maksoud F, Elnaggar M, Tawfeek H, Tamam H. Mizolastine-loaded spanlastics for treatment of atopic dermatitis: immunomodulatory approach for management of inflammation. Journal of Drug Targeting. 2025;:1 [Crossref]
3- Ghumare G, Salve P, Hussain U, Tatode A, Qutub M, Premchandani T, Tammewar S. Nanotechnology-Driven Transdermal System for Loxapine Succinate: A Novel Strategy To Improve Pharmacokinetics and Therapeutics in Psychotic Disorders. J Pharm Innov. 2025;20(5) [Crossref]
4- Gautam A, Wairkar S. DoE-based Development of Transdermal Risedronate-laden Cubosomes: In Vitro Characterization, Drug Deposition, and In Vivo Permeation in Rats. AAPS PharmSciTech. 2026;27(3) [Crossref]
5- Seenivasan R, Halagali P, Nayak D, Tippavajhala V. Transethosomes: A Comprehensive Review of Ultra-Deformable Vesicular Systems for Enhanced Transdermal Drug Delivery. AAPS PharmSciTech. 2025;26(1) [Crossref]
6- Brock G, Hellstrom W, Giraldi A, Honig S. Addressing unmet needs for patients with erectile dysfunction: a narrative review of topical therapies. 2025;13(2) [Crossref]
7- Hussein H, ِِAlyoussef Alkrad J, Hassouneh L, Mestareehi A, AlKhatib H, Assaf S, Dahmash E. Developing and Evaluating Stable Microemulsion Systems for Potential Intranasal and Transdermal Application of Omeprazole. AAPS PharmSciTech. 2026;27(3) [Crossref]
8- Singhal P, Mazumder R, Rani A, Debnath A. Development of Transdermal Drug Delivery Approaches to Combat Diabetes: An Update. CDM. 2025;26(6):361 [Crossref]
9- Addissouky T. Advancing frontiers in skin offensive odor management: from innovative diagnostics to cutting-edge treatments and emerging technologies. Arch Dermatol Res. 2025;317(1) [Crossref]
10- Mehta P. Advancing transdermal drug delivery through 4D bioprinting and dynamic skin modelling. Front Drug Deliv. 2026;6 [Crossref]
11- Momin Z, D. M, B. P, K. V, Kumar L. Formulation, characterization, and evaluation of transdermal patches of ranolazine for chronic angina pectoris. Naunyn-Schmiedeberg's Arch Pharmacol. 2026;399(2):2227 [Crossref]
12- Rahamathulla M, Devanshi S, Saisivam S, Kalaria V, Chakraborty S, Hani U, Ahmed M, Thajudeen K. Formulation and Characterization of Nadolol Transdermal Delivery Using 3² Factorial Design: In Vitro and Ex Vivo Evaluation. J Pharm Innov. 2026;21(1) [Crossref]
13- Shinde P, Page A. Ultra-stabilized transethosomal gel for co-delivery of 5-fluorouracil and carvedilol: cytotoxicity and in vivo studies in skin cancer . Drug Development and Industrial Pharmacy. 2026;:1 [Crossref]
14- Sultana N, Al Kausor M. Eutectic formulations in pharmaceutical development: a comprehensive review of modulation strategies. RSC Pharm. 2025;2(6):1408 [Crossref]
15- Parada-Silgado A, Cabarcas-Lara E, Rhenals-Perez G, Rhenals-Perez J, León-Mendez G, Osorio-Fortich M. Nanotecnología aplicada a la liberación transdérmica de medicamentos nanoparches, vesículas lipídicas y dendrímeros. Tek rev cient. 2025;25(1):71 [Crossref]
16- Raj A, Nirbhavane P, Gandhi H, Yadav S, Kalra A, Sardana S. Quality by design-driven approach to develop a nanocarrier-based sulfasalazine topical system for rheumatoid arthritis management. Drug Development and Industrial Pharmacy. 2026;:1 [Crossref]
17- Panda P, Mohanty T, Mohapatra R. Advancements in Transdermal Drug Delivery Systems: Harnessing the Potential of Macromolecular Assisted Permeation Enhancement and Novel Techniques. AAPS PharmSciTech. 2025;26(1) [Crossref]
18- Yakimov K, Nogaeva U, Flisyuk E. Development and pharmacotechnological studies of transdermal patches with trans-resveratrol. Razrabotka i registraciâ lekarstvennyh sredstv. 2025;14(4):125 [Crossref]
19- Tanaka K, Kawaguchi Y, Wakabayashi R, Kato K, Kamiya N, Goto M. Enhancement of Transdermal Delivery and Vaccine Effect via Chemical Permeation Enhancers Integrated Solid-in-Oil Dispersions. ACS Biomater Sci Eng. 2026;12(1):395 [Crossref]
20- Arguello A, Sadhnani G, Leung J, Moawad F, Cullis P, Hedtrich S, Brambilla D. Spatially Defined Post-manufacturing Loading of Nanoparticles into Hydrogel-Forming Microneedles. Mol Pharmaceutics. 2025;22(8):4778 [Crossref]
21- Gopal K, Mahmood S, Sofian Z, Hilles A, Hashim N. Microneedle Innovations in Oral Therapeutics: Transforming Protein and Peptide Delivery. AAPS PharmSciTech. 2025;26(5) [Crossref]
22- Bajwa N, Devulapalli V, Devulapalli M, Gopi K, Shariff S, Kumar P, Quispe-Vicuña C. Microneedle technology: a gateway to transformative healthcare solutions. theevi. 2024;2(3) [Crossref]
23- Kalambhe D, Shelke O, Deshpande A, Huang Y. In-vitro Efficacy and In-vivo Safety Study of a Transdermal Formulation Containing ‎Flavonoid-Rich Extract from Curcuma Longa L.. J Pharm Innov. 2026;21(1) [Crossref]
24- Hulyalkar S, Dandagi P, Biradar P, Muppayyanamath A, Kurani S. Development of Quality by Design Based Novel Zaltoprofen Cubosomal Gel for its improved Anti-Inflammatory Therapy by Transdermal Delivery: Formulation, Characterization, and In Vivo Evaluation. BioNanoSci. 2026;16(3) [Crossref]